OBJECTIVE: Diagnosis of small for gestational age (SGA) newborns often occurs in the setting of pre-eclampsia (PreE) due to placental insufficiency. However, it is unclear whether the poor outcomes associated with SGA are caused by co-existing PreE, or simply related to the early gestational age (GA) at which these neonates deliver. STUDY DESIGN: This is a secondary analysis of a prospective multicenter study designed to evaluate the role of placental growth factor in predicting PreE. Women were included in the parent study if they presented with concern for developing PreE. In our analysis, all women from the parent study with singleton, non-anomalous pregnancies who delivered a neonate with SGA were included. Women who developed PreE were compared to those who did not. The primary outcome was composite neonatal morbidity and mortality (Table 1) . Secondary outcomes included respiratory distress syndrome (RDS), 5-minute Apgar score < 4, arterial cord gas pH less than 7.1, and cesarean delivery. Univariate analysis was performed to compare characteristics and outcomes between the groups. To control for GA, the groups were compared after stratification (i.e. delivery before vs after 32 weeks GA). Finally, multivariate logistic regression models were fit to determine adjusted odds ratios associated with PreE and GA at delivery for each outcome. RESULTS: Of the 337 women that delivered an SGA neonate, 258 (77%) had PreE and 79 (23%) did not. The two groups had similar maternal age, BMI, rates of chronic hypertension, and pre-gestational diabetes. Women that developed PreE were more likely to be nulliparous, African American, or have pre-existing renal disease. Women that developed PreE delivered at earlier gestational ages (33 vs. 36 weeks, p < 0.01) with higher rates of composite neonatal morbidity (12% vs. 4%, p < 0.01) and Cesarean delivery (65% vs. 51%, p ¼ 0.02, Table 1 ). However, after stratification by gestational age, there were no differences in any of these outcomes (Table 2) . By multivariate analysis, PreE did not contribute to neonatal morbidity (OR ¼ 1.3, 95% CI 0.3 e 6.9). Instead, decreasing GA at delivery was strongly associated with neonatal morbidity (OR ¼ 0.6, 95% CI 0.5 e 0.7). CONCLUSION: Among SGA newborns, GA at delivery, not concomitant PreE, is associated with neonatal morbidity. Risk of RDS, low Apgars scores, and Cesarean delivery are also independent of PreE. OBJECTIVE: How race is associated with adverse outcomes in the setting of preeclampsia is not well characterized. The objective of this study was to assess maternal outcomes by race in the setting of preeclampsia. STUDY DESIGN: This retrospective cohort study utilized the Nationwide Inpatient Sample (NIS) from 2012 to 2014. Women age 15 to 54 with preeclampsia were included. Race and ethnicity were categorized as non-Hispanic white, non-Hispanic black, Hispanic, Asian or Pacific Islander, Native American, other, and unknown. Overall risk for severe morbidity based on CDC criteria was analyzed along with specific outcomes such as stroke, acute heart failure or pulmonary edema (AHF/PE), eclampsia, and acute renal failure. Risk for severe morbidity was stratified by comorbid risk and compared by race. Log-linear models were created to assess risk for severe morbidity accounting for comorbidity, demographic, and hospital factors with risk ratios (RR) and 95% confidence intervals (CI) as measures of effect. RESULTS: 101,741 women with preeclampsia from 2012 to 2014 were included in this analysis. Risk for severe morbidity was significantly higher among non-Hispanic black women (9.8%) than non-Hispanic white, Hispanic, and all other women respectively (6.1%, 7.7%, and 7.5% respectively, p<0.01). For non-Hispanic black compared to non-Hispanic white, Hispanic, and all other women risk was higher for stroke (17.1 versus 6.5, 12.7, and 9.3 per 10,000 deliveries respectively, p<0.01) and AHF/PE (56.2 versus 32.7, 30.2, and 38.4 per 10,000 deliveries respectively, p<0.01 (Figure 1 ). NonHispanic black women were also more likely than non-Hispanic white women to experience renal failure (136.4 versus 60.4 per 10,000 deliveries, p<0.01) and eclampsia (171.1 versus 133.6 per 10,000 deliveries, p<0.01) (Figure 2) . Adjusting for comorbidity, demographic, and hospital factors, black women remained at higher risk for severe morbidity (RR 1.60 95% CI 1.51-1.69). Risk for death was higher for black compared to non-black women (121.8 per 100,000 deliveries, 95% CI 69.7-212.9 versus 24.1 per 100,000 deliveries, 95% CI 14.6-39.8, respectively, p<0.01). CONCLUSION: Black women were at higher risk for severe morbidity and mortality associated with preeclampsia. Addressing these differentials may be important in efforts to reduce overall racial disparities.
